Loading
CT
CALMARE THERAPEUTICS Inc Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Hornidge Richard D, was filed 27 Sept 2012.
CALMARE THERAPEUTICS Inc: what insiders have been doing
CALMARE THERAPEUTICS Inc is a listed company. Its directors and officers file their transactions with SEC (Form 4). No insider at CALMARE THERAPEUTICS Inc has published a filing in the past twelve months. The most recent one dates from 6 March 2018.
Looking back to 2006, when coverage begins, insiders filed 77 purchases and 4 sales.
This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
133
Thresholds
n/a
Buy Volume
€254,413
77 ops. · all time
Sell Volume
€23,718
4 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2011FY ended December 2011 · cache
Income statement
Revenue3M
Gross profit702.2k24% margin
Net income-3.4M-115.0% margin
Last declaration on 6 March 2018
Declarations133 total
1,000,000 shares@ US$0.08100.0% of flowCommon StockSEC:0001615774-18-001626:0
4,594,117 sharesCommon StockSEC:0001615774-18-001625:0
333,333 shares@ US$0.09100.0% of flowCommon StockSEC:0001615774-18-001627:0
2,500 shares0Common StockSEC:0001615774-15-001339:0
2,500 shares0Common StockSEC:0001615774-15-001309:0
2,500 shares0Common StockSEC:0001615774-15-001148:0
2,500 shares0Common StockSEC:0001615774-15-001126:0
2,500 shares0Common StockSEC:0001144204-14-042217:0
2,500 shares0Common StockSEC:0001144204-14-041443:0
2,500 shares0Common StockSEC:0001360865-13-000034:0
5,000 shares0Common StockSEC:0001360865-13-000038:0
5,000 shares0Common StockSEC:0001360865-13-000035:0
2,500 shares0Common StockSEC:0001360865-13-000033:0
5,000 shares0Common StockSEC:0001360865-13-000037:0
2,500 shares0Common StockSEC:0001360865-13-000036:0
121,960 shares@ US$0.47Common StockSEC:0001360865-12-000306:0
2,500 shares@ US$0.59Common StockSEC:0001360865-12-000199:0
Canonical exit: 26 Dec 2012 (T+90)
5,000 shares@ US$0.85Common StockSEC:0001360865-12-000140:1
Canonical exit: 3 Dec 2012 (T+90)
3,000 shares@ US$0.93Common StockSEC:0001360865-12-000140:0
Canonical exit: 22 Nov 2012 (T+90)
3,500 shares@ US$0.95Common StockSEC:0001360865-12-000094:0
Canonical exit: 20 Aug 2012 (T+90)
1,500 shares@ US$0.98Common StockSEC:0001360865-12-000094:1
Canonical exit: 20 Aug 2012 (T+90)
4,964 shares@ US$1.41Common StockSEC:0001360865-11-000207:0
Canonical exit: 20 Nov 2011 (T+90)
4,255 shares@ US$1.41Common StockSEC:0001360865-11-000206:0
Canonical exit: 22 Nov 2011 (T+90)
2,500 shares0Common StockSEC:0001360865-11-000111:0
2,500 shares0Common StockSEC:0001360865-11-000114:0
25 of 133 declarations
About CALMARE THERAPEUTICS Inc
CALMARE THERAPEUTICS Inc is a company focused on developing innovative treatments for pain management. It is listed on NASDAQ under the symbol XNAS.
